Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
115.50
100.20
82.72
68.11
56.45
53.62
46.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
115.50
100.20
82.72
68.11
56.45
53.62
46.61
Raw Material Cost
37.26
38.96
28.15
22.92
18.56
15.54
13.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
8.04
6.81
5.10
4.29
3.71
3.26
2.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.72
1.19
0.33
0.24
0.24
0.25
0.23
Selling and Distribution Expenses
49.50
37.30
31.17
26.13
24.08
24.87
21.54
Other Expenses
-0.85
-0.68
-0.49
-0.41
-0.33
-0.24
-0.14
Total Expenditure (Excl Depreciation)
88.05
77.43
59.83
49.44
43.28
41.56
36.41
Operating Profit (PBDIT) excl Other Income
27.5
22.799999999999997
22.9
18.700000000000003
13.200000000000001
12.1
10.2
Other Income
1.57
1.31
0.64
0.17
0.28
0.27
0.16
Operating Profit (PBDIT)
31.72
26.17
24.46
19.61
14.18
12.93
10.61
Interest
1.72
1.19
0.33
0.24
0.24
0.25
0.23
Exceptional Items
0.29
0.36
0.15
0.18
0.10
-0.01
0.75
Gross Profit (PBDT)
78.24
61.24
54.57
45.19
37.88
38.08
33.35
Depreciation
3.25
2.42
1.14
1.01
0.93
0.83
0.57
Profit Before Tax
27.04
22.92
23.14
18.55
13.10
11.84
10.55
Tax
10.49
10.09
8.09
4.78
-0.97
3.38
2.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.61
12.83
15.05
13.77
14.07
8.45
8.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.61
12.83
15.05
13.77
14.07
8.45
8.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.06
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.55
12.83
15.05
13.77
14.07
8.45
8.56
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
62.16
54.41
50.95
45.08
37.73
28.13
24.44
Earnings per share (EPS)
1.73
1.33
1.56
1.42
1.45
0.87
0.88
Diluted Earnings per share
1.73
1.33
1.56
1.42
1.45
0.87
0.88
Operating Profit Margin (Excl OI)
23.29%
22.39%
27.41%
27.07%
22.98%
22.05%
21.19%
Gross Profit Margin
26.23%
25.29%
29.35%
28.71%
24.86%
23.63%
23.87%
PAT Margin
14.38%
12.81%
18.19%
20.22%
24.93%
15.77%
18.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 15.27% vs 21.16% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 29.69% vs -14.67% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 21.29% vs 4.62% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 41.67% vs 300.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Pharmanutra SpA With
Figures in Million
Consolidate Annual Results
Change(EUR)
Change(%)
Net Sales
115.50
23.79
91.71
385.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
115.50
23.79
91.71
385.50%
Raw Material Cost
37.26
16.13
21.13
131.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
8.04
6.47
1.57
24.27%
Power Cost
0
0
0.00
Manufacturing Expenses
1.72
0.35
1.37
391.43%
Selling and Distribution Expenses
49.50
3.62
45.88
1,267.40%
Other Expenses
-0.85
-0.68
-0.17
-25.00%
Total Expenditure (Excl Depreciation)
88.05
19.76
68.29
345.60%
Operating Profit (PBDIT) excl Other Income
27.45
4.03
23.42
581.14%
Other Income
1.57
-0.40
1.97
492.50%
Operating Profit (PBDIT)
31.72
5.38
26.34
489.59%
Interest
1.72
0.35
1.37
391.43%
Exceptional Items
0.29
-0.16
0.45
281.25%
Gross Profit (PBDT)
78.24
7.66
70.58
921.41%
Depreciation
3.25
1.64
1.61
98.17%
Profit Before Tax
27.04
3.23
23.81
737.15%
Tax
10.49
0.29
10.20
3,517.24%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
16.61
2.94
13.67
464.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
16.61
2.94
13.67
464.97%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-0.06
0.00
-0.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.55
2.94
13.61
462.93%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
62.16
18.36
43.80
238.56%
Earnings per share (EPS)
1.73
0.24
1.49
620.83%
Diluted Earnings per share
1.73
0.24
1.49
620.83%
Operating Profit Margin (Excl OI)
23.29%
17.41%
0.00
5.88%
Gross Profit Margin
26.23%
20.45%
0.00
5.78%
PAT Margin
14.38%
12.36%
0.00
2.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 11.55 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 15.27% vs 21.16% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 1.66 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 29.69% vs -14.67% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.02 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 21.29% vs 4.62% in Dec 2023
Annual - Interest
Interest 0.17 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 41.67% vs 300.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.29%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






